Multimodal Imaging and Management of Early Mitral Annuloplasty Ring Dehiscence with Pericardial Hematoma Authors: José Martín Alanís-Naranjo, Felipe Sebastián Figueroa-Galván, Ana María Rosas-Vázquez, María Eugenia Ruiz Esparza-Dueñas, Aloha Meave-González, Daniel Campuzano-González Published: 2026 ABSTRACT Graphical abstract Introduction Mitral annuloplasty ring dehiscence represents a rare postoperative, procedure-related complication of mitral valve (MV) repair.1, 2, 3 Pericardial hematoma refers to blood accumulation within the pericardial space and may occur after cardiac surgery or other invasive cardiac procedures.4,5 No published reports depict the use of multimodal imaging in patients with concomitant mitral annuloplasty ring dehiscence and pericardial hematoma. We report the case of a young man with prior mitral an tricuspid ring annuloplasty who presented with sudden dyspnea and was ultimately diagnosed with mitral annuloplasty ring dehiscence associated with a pericardial hematoma, identified using comprehensive multimodal imaging. Case Presentation A 24-year-old man was admitted for comprehensive evaluation because of progressive dyspnea that had advanced to symptoms at rest and a newly detected cardiac murmur. Medical history included Barlow disease with severe mitral regurgitation (MR) and tricuspid regurgitation associated with atrial fibrillation, treated 7 months earlier with mitral and tricuspid annuloplasty ring implantation, plus surgical exclusion of the left atrial appendage. At admission, vital signs showed a heart rate of 84 bpm and blood pressure of 107/74 mm Hg, with tachypnea at 24 bpm and an oxygen saturation of 94% on room air. Physical examination revealed systolic grade 3 murmur at the mitral area. Blood tests showed elevated N-terminal pro b-type natriuretic peptide levels of 2,396 pg/mL (reference range, 5-344 pg/mL). Electrocardiography showed no arrhythmias (Figure 1A), and chest radiography demonstrated global cardiomegaly (Figure 1B). Contrast-enhanced chest computed tomography (CT) revealed large pericardial effusion and posterior mitral annuloplasty ring dehiscence (Figure 1C-1F). Echocardiography confirmed severe MR secondary to posterior mitral annuloplasty ring dehiscence (Table 1, Figures 2 and 3, Videos 1-4). Cardiovascular magnetic resonance (CMR) provided additional tissue characterization, demonstrating a pericardial hematoma and biventricular systolic dysfunction, with a left ventricular ejection fraction of 48% and right ventricular ejection fraction of 27% (Figures 4 and 5, Videos 5-7).Figure 1Twelve-lead electrocardiogram (A) demonstrates normal sinus rhythm, normal QRS voltage, and nonspecific ST-T changes; chest radiograph (B) demonstrates dilated cardiac silhouette; cardiac CT, multiplanar, color-coded coronal display (C), volume-rendered three-dimensional reconstruction (D), axial (E) and oblique sagittal (F) displays, demonstrates the large pericardial effusion (stars) and posterior mitral annuloplasty ring dehiscence with large coaptation gap (arrows). Ao, Aorta; LA, left atrium; LV, left ventricle; PA, pulmonary artery; RA, right atrium; RV, right ventricle.Table 1Echocardiographic evaluationPrior valvular repairMitral ring dehiscenceLVEDV, mL/m293112LVEF, %6257TAPSE, mm2114Tissue Doppler S wave, cm/s117RAVi, mL/m25726LAVi, mL/m2172243Effective regurgitant orifice, cm2—1.3Regurgitant volume, mL—325Regurgitant fraction, %—65LAVi, left atrial volume index; LV, left ventricle; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; RAVi, right atrial volume index; RV, right ventricle; TAPSE, tricuspid annular plane systolic excursion.Figure 2Two-dimensional (2D) transthoracic echocardiography, apical 4-chamber diastolic (A, C) and systolic (B, D) views without (A, B) and with (C, D) color-flow Doppler, demonstrates left-sided chamber dilation, and mitral annuloplasty ring dehiscence with a large coaptation gap (arrows) and severe MR; a pericardial effusion is also noted (asterisks). Continuous- (E) and pulsed-wave (F) spectral Doppler displays demonstrate the MR and left ventricular outflow tract profiles, respectively. LA, Left atrium; LV, left ventricle; RA, right atrium; RV, right ventricleFigure 3Two-dimensional TEE, midesophageal 4-chamber diastolic (A) and systolic (B) views, and midesophageal long-axis (left ventricular outflow tract) diastolic (C) and systolic (D) views with color-flow Doppler, demonstrates mitral annuloplasty ring dehiscence with a large coaptation gap (arrows) and severe MR. The regurgitant jet originates at the P1-P2 leaflet level in 4-chamber view (B) and at the P2 scallop in the long-axis view (D). Three-dimensional TEE, midesophageal, volume-rendered short-axis diastolic (E) and systolic (F) reconstructions from the left atrial perspective, demonstrates a maximal separation of 23 mm toward the posterior wall. Ao, Aorta; LA, left atrium; LV, left ventricle; RV, right ventricle.Figure 4Cardiovascular magnetic resonance, balanced steady-state free precession (bSSFP) sequences, 4-chamber (A, B), 2-chamber (C, D), and midventricular short-axis (E, F) displays in diastole (A, C, E) and systole (B, D, F), demonstrate left-sided chamber dilation, mitral annuloplasty ring dehiscence with a large coaptation gap (arrows) and signal loss consistent with severe MR, and a large, complex pericardial effusion (asterisks). LA, Left atrium; LV, left ventricle; RA, right atrium; RV, right ventricleFigure 5Cardiovascular magnetic resonance, midventricular short-axis views with multiple sequences for tissue characterization including bSSFP (A), STIR (short tau inversion recovery) (B), native (C) and postcontrast (D) T1 mapping, T2∗ map (E), T2 map (F), strain (G), first-pass perfusion (H), and late-gadolinium enhancement (I,J and K). These sequences demonstrate anterior myocardial hypokinesis, pericardial thickening (5.5 mm), and a large, circumferential pericardial effusion (maximum size 4.8 cm) with multiple strands; mildly increased native T1 values in the basal inferolateral and inferoseptal segments (1,015 ms); extracellular volume of 33% in the myocardium and 5% in the pericardial effusion; normal T2∗ values (35 ms); normal myocardial T2 values (41 ms) and increased T2 values within the pericardial effusion (76 ms); normal global circumferential (−20.7%) and global peak radial (37%) strain values; normal myocardial perfusion; and focal LGE in the basal inferoseptal intramyocardial segment, the biatrial walls, and the pericardium. Twelve-lead electrocardiogram (A) demonstrates normal sinus rhythm, normal QRS voltage, and nonspecific ST-T changes; chest radiograph (B) demonstrates dilated cardiac silhouette; cardiac CT, multiplanar, color-coded coronal display (C), volume-rendered three-dimensional reconstruction (D), axial (E) and oblique sagittal (F) displays, demonstrates the large pericardial effusion (stars) and posterior mitral annuloplasty ring dehiscence with large coaptation gap (arrows). Ao, Aorta; LA, left atrium; LV, left ventricle; PA, pulmonary artery; RA, right atrium; RV, right ventricle. Table 1Echocardiographic evaluationPrior valvular repairMitral ring dehiscenceLVEDV, mL/m293112LVEF, %6257TAPSE, mm2114Tissue Doppler S wave, cm/s117RAVi, mL/m25726LAVi, mL/m2172243Effective regurgitant orifice, cm2—1.3Regurgitant volume, mL—325Regurgitant fraction, %—65LAVi, left atrial volume index; LV, left ventricle; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; RAVi, right atrial volume index; RV, right ventricle; TAPSE, tricuspid annular plane systolic excursion. Echocardiographic evaluation LAVi, left atrial volume index; LV, left ventricle; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; RAVi, right atrial volume index; RV, right ventricle; TAPSE, tricuspid annular plane systolic excursion. Two-dimensional (2D) transthoracic echocardiography, apical 4-chamber diastolic (A, C) and systolic (B, D) views without (A, B) and with (C, D) color-flow Doppler, demonstrates left-sided chamber dilation, and mitral annuloplasty ring dehiscence with a large coaptation gap (arrows) and severe MR; a pericardial effusion is also noted (asterisks). Continuous- (E) and pulsed-wave (F) spectral Doppler displays demonstrate the MR and left ventricular outflow tract profiles, respectively. LA, Left atrium; LV, left ventricle; RA, right atrium; RV, right ventricle Two-dimensional TEE, midesophageal 4-chamber diastolic (A) and systolic (B) views, and midesophageal long-axis (left ventricular outflow tract) diastolic (C) and systolic (D) views with color-flow Doppler, demonstrates mitral annuloplasty ring dehiscence with a large coaptation gap (arrows) and severe MR. The regurgitant jet originates at the P1-P2 leaflet level in 4-chamber view (B) and at the P2 scallop in the long-axis view (D). Three-dimensional TEE, midesophageal, volume-rendered short-axis diastolic (E) and systolic (F) reconstructions from the left atrial perspective, demonstrates a maximal separation of 23 mm toward the posterior wall. Ao, Aorta; LA, left atrium; LV, left ventricle; RV, right ventricle. Cardiovascular magnetic resonance, balanced steady-state free precession (bSSFP) sequences, 4-chamber (A, B), 2-chamber (C, D), and midventricular short-axis (E, F) displays in diastole (A, C, E) and systole (B, D, F), demonstrate left-sided chamber dilation, mitral annuloplasty ring dehiscence with a large coaptation gap (arrows) and signal loss consistent with severe MR, and a large, complex pericardial effusion (asterisks). LA, Left atrium; LV, left ventricle; RA, right atrium; RV, right ventricle Cardiovascular magnetic resonance, midventricular short-axis views with multiple sequences for tissue characterization including bSSFP (A), STIR (short tau inversion recovery) (B), native (C) and postcontrast (D) T1 mapping, T2∗ map (E), T2 map (F), strain (G), first-pass perfusion (H), and late-gadolinium enhancement (I,J and K). These sequences demonstrate anterior myocardial hypokinesis, pericardial thickening (5.5 mm), and a large, circumferential pericardial effusion (maximum size 4.8 cm) with multiple strands; mildly increased native T1 values in the basal inferolateral and inferoseptal segments (1,015 ms); extracellular volume of 33% in the myocardium and 5% in the pericardial effusion; normal T2∗ values (35 ms); normal myocardial T2 values (41 ms) and increased T2 values within the pericardial effusion (76 ms); normal global circumferential (−20.7%) and global peak radial (37%) strain values; normal myocardial perfusion; and focal LGE in the basal inferoseptal intramyocardial segment, the biatrial walls, and the pericardium. In the context of acute heart failure with biventricular systolic dysfunction and severe MR, urgent surgery was undertaken. The procedure consisted of MV replacement along with drainage of the pericardial hematoma. The immediate postoperative course was complicated by severe hemodynamic deterioration despite high-dose vasopressor and inotropic support, prompting initiation of extracorporeal membrane oxygenation. Hemodynamic recovery allowed device removal on postoperative day 4. Hospital-acquired pneumonia further prolonged recovery and hospitalization. The patient achieved clinical improvement and left the hospital on day 30 receiving guideline-directed medical therapy for heart failure and oral anticoagulation, remaining asymptomatic during outpatient follow-up. Discussion In severe primary MR, surgical MV repair with annuloplasty aimed at restoring normal valve anatomy remains the preferred strategy when a durable result is expected. In appropriately selected candidates, this procedure is associated with a low operative mortality of around 1.2%.6 Mitral valve repair aims to restore leaflet motion, improve leaflet coaptation, and stabilize the mitral annulus while maintaining an adequate valve orifice.7 In most patients with MV disease and annular dilation, ring annuloplasty stabilizes the annulus, prevents subsequent annular dilation, and restores the annular geometry.1,7 Compared with valve replacement, MV repair is associated with lower perioperative mortality as well as superior long-term survival and functional outcomes.6 Mitral valve replacement with preservation of the subvalvular apparatus represents the recommended alternative when MV repair cannot be achieved. In selected high-risk or elderly patients with chronic primary MR, a less invasive transcatheter edge-to-edge repair may be beneficial. Physicians should individualize the decision between intervention and conservative management by considering clinical status, anatomical features, procedural risk, and patient preference.6 Ring dehiscence is associated with recurrent MR, acute heart failure, intravascular hemolysis, device migration or embolization, and commonly requires urgent or emergent reoperation.2,7 Suture detachment from the annular tissue leads to partial or complete separation of the annuloplasty ring.1,3 The reported incidence ranges from approximately 1.2% to 3.0%,3 with significant variations across MV studies.1 According to the interval from the index repair, dehiscence is classified as acute (<30 days), early (30 days to 1 year), or late (>1 year).3 The surgical management of MV dysfunction has evolved over time. Increased surgical experience and improved understanding of mechanisms of repair failure, particularly annuloplasty ring dehiscence, have led to a consistent increase in MV re-repair.3 Risk factors for pericardial hematoma after open cardiac surgery include abnormal bleeding or coagulopathy, early anticoagulant use, redo procedures, valve surgery, and aortic surgery. Pericardial hematoma may remain asymptomatic when small or cause compression of heart structures when large.4 Our case report describes a patient who developed recurrent severe MR following prior MV repair as a result of annuloplasty ring dehiscence. This case illustrates an uncommon mechanism of MV repair failure and emphasizes the clinical significance of identifying the underlying cause of recurrent MR to guide optimal management. Technical factors, device characteristics, hemodynamic conditions, and annular microstructure play a role in the development of ring dehiscence. In patients undergoing isolated MV repair with ring annuloplasty, 1.6% required reoperation for symptomatic ring dehiscence, with a predominance of men (75%).3 Annuloplasty ring dehiscence remains unpredictable and occurs across all MV repair techniques. Ring dehiscence most commonly results in severe recurrent MR in 93% of patients and requires MV reoperation during the acute postoperative phase in 44% of cases.3 Ring dehiscence occurs more frequently with rigid annuloplasty rings and in cases of ischemic MR, whereas ring size and shape do not appear to influence dehiscence risk.1,7 In ischemic MR, annuloplasty alone addresses annular tethering but fails to address the underlying ventricular pathology, contributing to progressive and recurrent MR.1 Annuloplasty ring dehiscence most often involves the posterior annulus, particularly segment P3, likely due to lower collagen density and higher mechanical stress compared with the fibrous anterior annulus, a vulnerability further accentuated by annular dilation associated with MR.3 Early diagnosis of annuloplasty ring dehiscence is essential to prevent catastrophic complications and should be suspected in patients with prior valve surgery who develop a new heart murmur or signs of heart failure.1,2 Echocardiography remains the first-line imaging modality for the evaluation of prosthetic heart valve (PHV) function, particularly in patients presenting with new-onset heart failure symptoms. Transthoracic echocardiography is the initial approach, whereas transesophageal echocardiography (TEE) is preferred to define the mechanism of PHV dysfunction because to its superior spatial and temporal resolution and the absence of interference from thoracic structures. Although semi-invasive and requiring sedation, TEE provides detailed anatomical and hemodynamic assessment. Imaging strategies in PHV patients focus on detecting structural degeneration or dysfunction and identifying the underlying mechanism. Color-flow Doppler interrogation is essential for the assessment of regurgitation, allowing characterization of its location (central vs paravalvular) and severity.8 Three-dimensional TEE further enhances diagnostic accuracy by precisely defining mitral prosthetic anatomy, identifying annuloplasty ring dehiscence, quantifying regurgitation, and facilitating therapeutic decision-making.2,9 Cardiac CT provides high–spatial resolution, volumetric evaluation of the MV apparatus and prosthetic structures, enabling integrated anatomic and dynamic assessment throughout the cardiac cycle.6,10 Major clinical utility lies in defining the mechanism of prosthetic dysfunction when echocardiography remains inconclusive and in guiding surgical or transcatheter strategies.8,10 This modality supports procedural planning through accurate assessment of annular dimensions, mitral annular calcification, arterial access, risk of left ventricular outflow tract obstruction, and feasibility of transcatheter MV implantation.6,8,10 Noncontrast acquisition enables precise evaluation of mechanical leaflet mobility, whereas contrast-enhanced imaging facilitates differentiation between thrombus and pannus. Complementary value extends to PHV endocarditis by improving detection of periannular complications such as root abscess.10 Paravalvular leak can be identified by contrast-filled channels surrounding the prosthesis, allowing characterization of size, morphology, and location, as well as dynamic detection of prosthetic instability in dehiscence.8,10 Metallic artifacts may obscure small defects, requiring Doppler confirmation and attenuation analysis to distinguish them from pledgets.10 Cardiac CT also provides essential information for reintervention, including mediastinal relationships in redo surgery and evaluation of coronary obstruction risk and prosthetic anatomy for valve-in-valve procedures.8 Cardiovascular magnetic resonance is recommended when echocardiographic quantification of regurgitant volume and fraction is inconclusive or discordant, given its role as the reference standard for cardiac chamber volumes and dimensions.6 Assessment combines ventricular volumetric planimetry with phase-contrast flow measurements and provides complementary evaluation of PHV function. Imaging can be safely performed at 1.5 or 3-T field strengths.6,10 Cine sequences allow initial identification of prosthetic stenosis or regurgitation. Although steady-state free precession cines are susceptible to artifacts, fast gradient-echo and spin-echo sequences reduce flow- and prosthesis-related artifacts. When artifacts are minimal, cine imaging allows assessment of prosthetic motion and may help define the mechanism of regurgitation, including dehiscence, vegetation, or abscess.10 Quantitative evaluation of regurgitation remains the main strength of this modality and is based on calculation of regurgitant volume and fraction from left ventricular stroke volume derived from cine planimetry and aortic forward flow measured with through-plane phase-contrast imaging.10 In this case, CMR with dedicated cardiac plane acquisition also localized the site of mitral annuloplasty ring dehiscence and provided anatomical and functional information comparable to echocardiography. Late paravalvular leak should raise strong suspicion of infective endocarditis with valve dehiscence.8 Multimodality cardiac imaging is essential for diagnosis and surgical planning, as this approach enables precise characterization of prosthetic dehiscence and detection of concomitant vegetations, including those in atypical locations that may require intervention.10,11 Acute severe primary MR requires urgent surgical or transcatheter intervention because of limited hemodynamic tolerance.6 Reoperation in these cases is performed through either a median sternotomy or a right lateral mini-thoracotomy, with the decision to proceed with MV re-repair guided by intraoperative findings and surgeon judgment.3 In experienced centers, minimally invasive right mini-thoracotomy is increasingly used, showing safety and efficacy comparable to conventional sternotomy. This approach is associated with shorter hospital stay and faster recovery of physical activity during the first 6 weeks.6 Although MV re-repair has become increasingly common and reoperation for annuloplasty ring dehiscence is associated with low early mortality, annuloplasty ring dehiscence remains a serious complication associated with unfavorable repair outcomes.1,3 Mitral annuloplasty ring dehiscence with severe MR represents a complex clinical scenario in high-surgical-risk patients, since recurrent MR may involve both transring and pararing components and surgical reintervention is often prohibitive, which has driven increasing interest in transcatheter strategies as a less invasive yet effective alternative.12 Transcatheter edge-to-edge repair has demonstrated high procedural success, allowing reliable device deployment across the dehisced orifice with meaningful reduction in MR and clinical improvement when guided by comprehensive imaging and meticulous procedural planning, with most patients requiring a single device.12,13 Valve-in-ring transcatheter MV implantation may serve as a complementary option in selected cases, with acceptable early- and midterm survival despite greater procedural complexity and higher complication rates compared with valve-in-valve procedures, while improvement in pararing regurgitation may be explained by expansion of the circular prosthesis that enhances posterior annular contact, although long-term durability remains uncertain and requires further investigation.12 Echocardiographic follow-up is recommended at 6 and 12 months after MV repair and annually thereafter.3 Conclusion Multimodal cardiac imaging allowed accurate identification of mitral annuloplasty ring dehiscence complicated by pericardial hematoma, thereby guiding urgent surgical management in a complex post–mitral repair setting. Consent Statement Complete written informed consent was obtained from the patient (or appropriate parent, guardian, or power of attorney) for the publication of this study and accompanying images. Ethics Statement The authors declare that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. Disclosure Statement The authors reported no actual or potential conflicts of interest relative to this document.